{
  "catalogId": "5358c1bd-e175-4288-bd04-7231399ec2a7",
  "name": "TRANSLARNA 1000 MG",
  "status": "draft",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "154 28 34267 00",
  "treatmentDescriptions": "Translarna is indicated for the treatment of Duchenne muscular dystrophy resulting from a nonsense mutation in the dystrophin gene, in ambulatory patients aged 2 years and older.  The presence of a nonsense mutation in the dystrophin gene should be determined by genetic testing.",
  "termsOfIssue": "Prescription required",
  "form": "granules for oral suspension",
  "route": "per os",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "ATALUREN",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "M09AX03",
      "name": "ATALUREN"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "TRANSLARNA 125MG 30 SACHETS",
      "manufacturer": {
        "name": "מדיסון",
        "countryOfOrigin": "IL"
      },
      "strength": {
        "value": 0,
        "unit": ""
      },
      "quantity": {
        "value": 30.0,
        "unit": "units"
      },
      "packagingDescription": "SACHET ALUMINIUM",
      "shelfLife": "48",
      "storageConditions": "",
      "codes": {
        "moh": "7636",
        "yarpa": "16013",
        "pharmasoft": "9848"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": 12273.46324,
        "retailMargin": 10.0,
        "maxRetailPrice": 13500.80956,
        "maxPriceWithVAT": 15930.95458
      }
    }
  ],
  "metadata": {
    "version": "1.4",
    "lastUpdated": "2025-08-01T12:18:43.408403"
  }
}